Emmecell

EmmecellEmmecell
Emmecell

Emmecell

Developing magnetic cell delivery platform for advanced therapies.

2016Active12
Rate

About

Emmecell is a biotechnology company developing a proprietary Magnetic Cell Delivery nanoparticle platform to address challenges in localizing, retaining, and integrating cell therapies. This platform aims to improve regenerative medicine by enabling precise delivery of cells to target tissues. Emmecell is initially focusing its efforts on ophthalmic indications.

Technology stack

detected 2026-07-05
EmailMicrosoft 365
Stack
Wix
Observability
Sentry
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Emmecell do?

Emmecell is a biotechnology company developing a proprietary Magnetic Cell Delivery nanoparticle platform to address challenges in localizing, retaining, and integrating cell therapies. This platform aims to improve regenerative medicine by enabling precise delivery of cells to target tissues. Emmecell is initially focusing its efforts on ophthalmic indications.

Where is Emmecell headquartered?

Emmecell is headquartered in Menlo Park, California, USA.

When was Emmecell founded?

Emmecell was founded in 2016.

What industry does Emmecell operate in?

Emmecell operates in Biotechnology, HealthTech, Medical Devices, Biotech, MedTech, Drug Discovery.

How many employees does Emmecell have?

Emmecell has approximately 12 people on record.

What is Emmecell's revenue?

StartupHub estimates Emmecell's annual revenue at $1.5M (range $829K to $4.6M, 71% confidence), based on comparable companies in the sector.